POLICY FOR PATIENT GROUP DIRECTIONS (PGD) - NHS

6.2. Development Process steps6.2.1. Assessment of clinical need for a PGDThe following information is essential reading to help answer thequestions below.6.2.1.1. To PGD or not to PGD? – That is the question. Pharmacy CommunityCare Liaison Grouphttp://129.11.239.213/protocols/PGD%20flowchart%202xA4v2.doc6.2.1.2. NPC Patient Group Directions: A guide to good practice.http://www.npc.co.uk/pdf/pgd.pdf6.2.1.3. The individual manufacturers Summary of Product Characteristics(SPC), available on-line at http://www.medicines.org.uk/6.2.1.4. The service wishing to produce a PGD must answer the followingquestions and document supporting evidence for the clinical need of aPGD.6.2.1.5. Is a PGD the most appropriate method of providing treatment for thegroup of patients in the defined clinical situation?6.2.1.5.1. Is there a clearly defined gap in service that a PGD can address withoutcompromising patient safety?6.2.1.6. Is the recommended use included in the PGD consistent with theSummary of Product Characteristics (SPC) and NICE and locally agreedguidance where available? If not then the PGD may not be a feasibleoption6.2.1.7. How will supplies be obtained?6.2.1.8. Is there a safe storage area for medicines?6.2.2. PGD discussion groupA service wishing to develop a PGD is responsible for organising theappropriate discussion group, which should involve the followingpersonnel6.2.2.1. A senior doctor6.2.2.2. A senior pharmacist6.2.2.3. A representative of the professional group expected to operate withinthe PGD.6.2.2.4. Consultation with key stakeholdersPolicy for the development of Patient Group Directions (PGD)Page 8 of 23